What sector does Sam-A Pharm. Co. Ltd belong to?

Sam-A Pharm. Co. Ltd operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.

What is the current share price of 009300?

As of the latest available quote, 009300 traded at ₩13,950.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 009300?

Sam-A Pharm. Co. Ltd has a price-to-earnings (P/E) ratio of about 6.58. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 009300?

The market capitalisation of Sam-A Pharm. Co. Ltd is approximately ₩85.15B.

Is Sam-A Pharm. Co. Ltd profitable?

For its latest reported financial year, Sam-A Pharm. Co. Ltd recorded a net profit margin of about 16.63%.

Does 009300 pay a dividend?

Sam-A Pharm. Co. Ltd currently has a dividend yield of about 5.20%.

What is the return on equity (ROE) of 009300?

Sam-A Pharm. Co. Ltd has a return on equity (ROE) of about 5.67%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 009300?

Over the past 52 weeks, 009300 has traded between a low of ₩11,950.00 and a high of ₩17,480.00.

Sam-A Pharm. Co. Ltd

009300 KRX Pharmaceuticals Pharmaceuticals

KOSDAQ

₩13,950.00

+0.36%

Delayed · cached 15 min

Fair value analysis

009300

Sam-A Pharm. Co. Ltd

₩13,950.00

Close used for this calculation

₩27,740.70Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

76/100

Profitability15/25

Returns11/25

Balance Sheet25/25

Efficiency25/25

Growth14/25

Strong

Quality radar

Consensus fair value

₩27,740.70

Below FV

▲ +98.9% against the close used

Model range ₩8,586.00 – ₩46,922.67

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩8,586.00Fair value₩27,740.70Bull₩46,922.67

FairClose

52-week traded range

52W low ₩12,130.0052W high ₩14,050.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Sam-A Pharm. Co. Ltd closed at ₩13,950.00, 49.7% below the consensus fair value of ₩27,740.70 drawn from 10 valuation models.

Financial DNA score 76/100 — Strong. P/E of 6.6x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₩22,880.02

+64.0%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=4.1%, r=10%, tg=3%, n=10yr

Graham Number

₩42,407.77

+204.0%

√(22.5 × EPS × BVPS)

EPS=2120, BVPS=37702.7

Graham Formula

₩46,922.67

+236.4%

EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate

g=4.1%, FD=3.3%

P/E Fair Value

₩42,400.00

+203.9%

EPS × 20x (sector P/E)

EPS=2120, Sector P/E=20x

Peter Lynch (PEG)

₩8,586.00

-38.5%

EPS × Growth% (PEG = 1 is fair)

EPS=2120, g=4.1%

EV/EBITDA

₩21,629.84

+55.1%

(EBITDA × 12x − Net Debt) ÷ Shares

EBITDA=10.98B

Dividend Discount (DDM)

₩12,685.36

-9.1%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=725.4, r=10%, g=4.1%

Book Value (P/B)

₩10,265.27

-26.4%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=37702.7, ROE=5.7%, g=4.1%, r=10%

Reverse DCF

₩13,950.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: -8.3% | Historical: 4.1%

Margin of Safety

₩28,989.46

+107.8%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=38652.62, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer